Not exact matches
One of the
most contentious and closely scrutinized decisions before the FDA concerns Provenge, a proposed
therapeutic vaccine made by Dendreon for use against prostate
cancer.
A new
therapeutic vaccine, GTL001, developed by Genticel to clear HPV strains 16 and 18 — the types
most likely to cause
cancer — is being evaluated for safety in a Phase I clinical trial at the University of Louisville.
Most recently, CRI has launched a new «venture philanthropy» program called the
Cancer Vaccine Acceleration Fund (CVAF) as a means to catalyze development of next - generation therapeutic cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical t
Cancer Vaccine Acceleration Fund (CVAF) as a means to catalyze development of next - generation
therapeutic cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical t
cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical trials.
«Based on the clinical evidence we've gathered over the past decade in our
cancer vaccine trials,» Old said, «and in light of data from a variety of trials by others within the field, we believe
therapeutic cancer vaccines will increasingly emerge as one of the safest and
most powerful ways to combat a variety of
cancers.»